Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.Pageof 6